Omalizumab in persistent severe bakers' asthma.
Olivieri
M
M
Department of Medicine and Public Health, Unit of Occupational Medicine, University of Verona, Policlinico G. Rossi, Piazza L.A. Scuro, 1037134 Verona, Italy. mario.olivieri@univr.it
Biscardo
C A
CA
Turri
S
S
Perbellini
L
L
D000485:Allergens / Q000276:immunology; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy* / Q000276:immunology; D000069444:Omalizumab; D012882:Skin Tests; D021182:Wheat Hypersensitivity / Q000188:drug therapy* / Q000276:immunology
D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E